BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1701284)

  • 1. Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity.
    Plate KH; Rüschoff J; Behnke J; Mennel HD
    Acta Neurochir (Wien); 1990; 104(3-4):103-9. PubMed ID: 1701284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell proliferation in intracranial tumours: selective silver staining of nucleolar organizer regions (AgNORs). Application to surgical and experimental neuro-oncology.
    Plate KH; Rüschoff J; Mennel HD
    Neuropathol Appl Neurobiol; 1991 Apr; 17(2):121-32. PubMed ID: 1713308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.
    Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
    Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma.
    Pich A; Valente G; Azzoni L; Stramignoni A; Margaria E; Tasso M
    Pathol Res Pract; 1991 May; 187(4):482-6. PubMed ID: 1715079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [AgNOR in neurooncology].
    Martin H; Gottschalk J; Hufnagl P; Beil M
    Acta Histochem Suppl; 1992; 42():179-84. PubMed ID: 1584963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.
    Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
    Acta Neurochir (Wien); 1991; 109(1-2):37-41. PubMed ID: 1648862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multilabeling technique for simultaneous demonstration and quantitation of Ki-67 and nucleolar organizer regions (AgNORs) in paraffin-embedded tissue.
    Munakata S; Hendricks JB
    J Histochem Cytochem; 1994 Jun; 42(6):789-3. PubMed ID: 7514625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleolar organizer regions (AgNORs) in primary and recurrent gliomas. A retrospective study.
    Engel U; Plate K; Jänisch W; Mennel HD
    Zentralbl Pathol; 1994 Mar; 140(1):73-81. PubMed ID: 7515677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential demonstration of nucleolar organizer regions and Ki67 immunolabelling in non-Hodgkin's lymphomas.
    Janmohamed RM; Murray PG; Crocker J; Leyland MJ
    Clin Lab Haematol; 1990; 12(4):395-9. PubMed ID: 2081380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nucleolus organizer regions in pathomorphologic tumor diagnosis].
    Rüschoff J
    Veroff Pathol; 1992; 139():1-144. PubMed ID: 1413987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
    Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores.
    Soomro IN; Whimster WF
    J Pathol; 1990 Nov; 162(3):217-22. PubMed ID: 2266458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining.
    Trerè D; Farabegoli F; Cancellieri A; Ceccarelli C; Eusebi V; Derenzini M
    J Pathol; 1991 Sep; 165(1):53-9. PubMed ID: 1955936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain.
    Mourad WA; Connelly JH; Sembera DL; Atkinson EN; Bruner JM
    Hum Pathol; 1993 Feb; 24(2):206-10. PubMed ID: 8432516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
    Pich A; Chiarle R; Chiusa L; Palestro G
    Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.
    Onda K; Davis RL; Wilson CB; Hoshino T
    Acta Neuropathol; 1994; 87(6):586-93. PubMed ID: 8091951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organizer regions in cutaneous tumours.
    Egan MJ; Crocker J
    J Pathol; 1988 Mar; 154(3):247-53. PubMed ID: 2450982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
    Derenzini M; Trerè D
    Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.